De novo colorectal cancer after liver and kidney transplantation–Microenvironment disturbance

• Autor(a) principal: Oliveira, Rui Caetano
• Data de Publicação: 2020
• Outros Autores: Silva, Edgar Tavares da, Abrantes, Ana Margarida, Antunes, Hugo, Teixeira, Paulo, Gomes, Ana, Martins, Ricardo, Furtado, Emanuel, Figueiredo, Arnaldo, Costa, Beatriz, Cipriano, Maria Augusta, Tralhão, José Guilherme, Botelho, Maria Filomena
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10316/101503; https://doi.org/10.1016/j.tpr.2020.100057
• topic: Colorectal cancer; Tumour microenviroenment; Transplantation

Colorectal cancer (CRC) is a major health burden and may arise as a complication of solid organ transplantation. Our study aimed to assess the incidence of the CRC in kidney and liver transplanted patients at a tertiary and reference center and to describe their clinical and pathological features. Twelve patients, 10 men and two women, with a mean age of 60 years, composed our cohort, ten of them submitted to CRC resection. Transplanted organ was liver in five patients and kidney in seven. Regarding overall survival, patients submitted to renal transplantation were all deceased 5 years after CRC diagnosis, while those subjected to hepatic transplantation had a survival of 60% at the fifth year. Pathology examination showed seven patients with advanced disease (stage III/IV) and high amount of necrosis. Tumor microenvironment was disturbed, with low inflammatory infiltrate, absence of natural killer cells and no PD-L1 expression. CRC exhibited microsatellite instability in 40%, with expression of cancer stem cell markers (CD133, CD44 and ALDH1), as well as P53 (50%) and KRAS mutations (41.7%). CRC cancer after kidney and hepatic transplantation is a rare, but aggressive and deadly event. Regular follow-up should be instituted in these patients.